Cipla Gets USFDA Approval for Asthma Inhalation Drug Amid Rising Demand Due to Covid-19 Crisis

The US Food and Drug Administration approved Indian drugmaker Cipla Ltd to make the generic version of albuterol sulfate-based inhaler in a bid to help patients suffering from the coronavirus.

from Top India News- News18.com https://ift.tt/2Rmi359